 LONDON, Oct. 01, 2021 GLOBE NEWSWIRE -- Achilles Therapeutics plc NASDAQ: ACHL, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, will present an oral presentation at the 2021 European Society for Gene and Cell Therapy ESGCT Congress being held in a virtual format from October 19-22, 2021, and two posters at the Society for Immunotherapy of Cancer SITC 36th Annual Meeting being held in a hybrid format from November 10-14, 2021 online and in person in Washington, DC. 